Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon Signaling

Rodent-borne orthohantaviruses are asymptomatic in their natural reservoir, but they can cause severe diseases in humans. Although an exacerbated immune response relates to hantaviral pathologies, orthohantaviruses have to antagonize the antiviral interferon (IFN) response to successfully propagate...

Full description

Bibliographic Details
Main Authors: Giulia Gallo, Grégory Caignard, Karine Badonnel, Guillaume Chevreux, Samuel Terrier, Agnieszka Szemiel, Gleyder Roman-Sosa, Florian Binder, Quan Gu, Ana Da Silva Filipe, Rainer G. Ulrich, Alain Kohl, Damien Vitour, Noël Tordo, Myriam Ermonval
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/1/140
_version_ 1827599591111917568
author Giulia Gallo
Grégory Caignard
Karine Badonnel
Guillaume Chevreux
Samuel Terrier
Agnieszka Szemiel
Gleyder Roman-Sosa
Florian Binder
Quan Gu
Ana Da Silva Filipe
Rainer G. Ulrich
Alain Kohl
Damien Vitour
Noël Tordo
Myriam Ermonval
author_facet Giulia Gallo
Grégory Caignard
Karine Badonnel
Guillaume Chevreux
Samuel Terrier
Agnieszka Szemiel
Gleyder Roman-Sosa
Florian Binder
Quan Gu
Ana Da Silva Filipe
Rainer G. Ulrich
Alain Kohl
Damien Vitour
Noël Tordo
Myriam Ermonval
author_sort Giulia Gallo
collection DOAJ
description Rodent-borne orthohantaviruses are asymptomatic in their natural reservoir, but they can cause severe diseases in humans. Although an exacerbated immune response relates to hantaviral pathologies, orthohantaviruses have to antagonize the antiviral interferon (IFN) response to successfully propagate in infected cells. We studied interactions of structural and nonstructural (NSs) proteins of pathogenic Puumala (PUUV), low-pathogenic Tula (TULV), and non-pathogenic Prospect Hill (PHV) viruses, with human type I and III IFN (IFN-I and IFN-III) pathways. The NSs proteins of all three viruses inhibited the RIG-I-activated IFNβ promoter, while only the glycoprotein precursor (GPC) of PUUV, or its cleavage product Gn/Gc, and the nucleocapsid (N) of TULV inhibited it. Moreover, the GPC of both PUUV and TULV antagonized the promoter of IFN-stimulated responsive elements (ISRE). Different viral proteins could thus contribute to inhibition of IFNβ response in a viral context. While PUUV and TULV strains replicated similarly, whether expressing entire or truncated NSs proteins, only PUUV encoding a wild type NSs protein led to late IFN expression and activation of IFN-stimulated genes (ISG). This, together with the identification of particular domains of NSs proteins and different biological processes that are associated with cellular proteins in complex with NSs proteins, suggested that the activation of IFN-I is probably not the only antiviral pathway to be counteracted by orthohantaviruses and that NSs proteins could have multiple inhibitory functions.
first_indexed 2024-03-09T04:17:16Z
format Article
id doaj.art-a80738632ee44cc5bacfc3f5bc7cdb08
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T04:17:16Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-a80738632ee44cc5bacfc3f5bc7cdb082023-12-03T13:52:45ZengMDPI AGViruses1999-49152021-01-0113114010.3390/v13010140Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon SignalingGiulia Gallo0Grégory Caignard1Karine Badonnel2Guillaume Chevreux3Samuel Terrier4Agnieszka Szemiel5Gleyder Roman-Sosa6Florian Binder7Quan Gu8Ana Da Silva Filipe9Rainer G. Ulrich10Alain Kohl11Damien Vitour12Noël Tordo13Myriam Ermonval14Unité des Stratégies Antivirales, Institut Pasteur, 75015 Paris, FranceUMR 1161 Virologie, Anses-INRAE-EnvA, 94700 Maisons-Alfort, FranceBREED, INRAE, Université Paris-Saclay, 78350 Jouy-en-Josas, FranceInstitut Jacques Monod, CNRS UMR 7592, ProteoSeine Mass Spectrometry Plateform, Université de Paris, 75013 Paris, FranceInstitut Jacques Monod, CNRS UMR 7592, ProteoSeine Mass Spectrometry Plateform, Université de Paris, 75013 Paris, FranceMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UKUnité de Biologie Structurale, Institut Pasteur, 75015 Paris, FranceFriedrich-Loeffler-Institut, Institute of Novel and Emerging Infectious Diseases, 17493 Greifswald-Insel Riems, GermanyMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UKMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UKFriedrich-Loeffler-Institut, Institute of Novel and Emerging Infectious Diseases, 17493 Greifswald-Insel Riems, GermanyMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UKUMR 1161 Virologie, Anses-INRAE-EnvA, 94700 Maisons-Alfort, FranceUnité des Stratégies Antivirales, Institut Pasteur, 75015 Paris, FranceUnité des Stratégies Antivirales, Institut Pasteur, 75015 Paris, FranceRodent-borne orthohantaviruses are asymptomatic in their natural reservoir, but they can cause severe diseases in humans. Although an exacerbated immune response relates to hantaviral pathologies, orthohantaviruses have to antagonize the antiviral interferon (IFN) response to successfully propagate in infected cells. We studied interactions of structural and nonstructural (NSs) proteins of pathogenic Puumala (PUUV), low-pathogenic Tula (TULV), and non-pathogenic Prospect Hill (PHV) viruses, with human type I and III IFN (IFN-I and IFN-III) pathways. The NSs proteins of all three viruses inhibited the RIG-I-activated IFNβ promoter, while only the glycoprotein precursor (GPC) of PUUV, or its cleavage product Gn/Gc, and the nucleocapsid (N) of TULV inhibited it. Moreover, the GPC of both PUUV and TULV antagonized the promoter of IFN-stimulated responsive elements (ISRE). Different viral proteins could thus contribute to inhibition of IFNβ response in a viral context. While PUUV and TULV strains replicated similarly, whether expressing entire or truncated NSs proteins, only PUUV encoding a wild type NSs protein led to late IFN expression and activation of IFN-stimulated genes (ISG). This, together with the identification of particular domains of NSs proteins and different biological processes that are associated with cellular proteins in complex with NSs proteins, suggested that the activation of IFN-I is probably not the only antiviral pathway to be counteracted by orthohantaviruses and that NSs proteins could have multiple inhibitory functions.https://www.mdpi.com/1999-4915/13/1/140orthohantavirusinterferon responsenonstructural proteinglycoproteinPuumala virusTula virus
spellingShingle Giulia Gallo
Grégory Caignard
Karine Badonnel
Guillaume Chevreux
Samuel Terrier
Agnieszka Szemiel
Gleyder Roman-Sosa
Florian Binder
Quan Gu
Ana Da Silva Filipe
Rainer G. Ulrich
Alain Kohl
Damien Vitour
Noël Tordo
Myriam Ermonval
Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon Signaling
Viruses
orthohantavirus
interferon response
nonstructural protein
glycoprotein
Puumala virus
Tula virus
title Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon Signaling
title_full Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon Signaling
title_fullStr Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon Signaling
title_full_unstemmed Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon Signaling
title_short Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon Signaling
title_sort interactions of viral proteins from pathogenic and low or non pathogenic orthohantaviruses with human type i interferon signaling
topic orthohantavirus
interferon response
nonstructural protein
glycoprotein
Puumala virus
Tula virus
url https://www.mdpi.com/1999-4915/13/1/140
work_keys_str_mv AT giuliagallo interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT gregorycaignard interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT karinebadonnel interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT guillaumechevreux interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT samuelterrier interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT agnieszkaszemiel interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT gleyderromansosa interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT florianbinder interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT quangu interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT anadasilvafilipe interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT rainergulrich interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT alainkohl interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT damienvitour interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT noeltordo interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling
AT myriamermonval interactionsofviralproteinsfrompathogenicandlowornonpathogenicorthohantaviruseswithhumantypeiinterferonsignaling